3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
4
Unknown
1
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
26
Gastrointestinal
4
Genitourinary
3
Thoracic
1
Plasma cell
1
NET
1
Head & Neck
1
Gynecologic
1
Endocrine
1
CNS
1
Conditions
Squamous Cell Carcinoma of Head and Neck
370
Head and Neck Neoplasms
356
Nasopharyngeal Carcinoma
140
Thyroid Neoplasms
124
Carcinoma, Non-Small-Cell Lung
93
Mouth Neoplasms
84
Melanoma
76
Breast Neoplasms
75
Oropharyngeal Neoplasms
72
Colorectal Neoplasms
68
Uterine Cervical Neoplasms
66
Lung Neoplasms
66
Neoplasms
63
Ovarian Neoplasms
61
Neoplasm Metastasis
52
Prostatic Neoplasms
51
Stomach Neoplasms
49
Pancreatic Neoplasms
47
Carcinoma, Squamous Cell
45
Triple Negative Breast Neoplasms
43
Laryngeal Neoplasms
42
Esophageal Neoplasms
42
Endometrial Neoplasms
42
Thyroid Nodule
37
Carcinoma, Renal Cell
37
Urinary Bladder Neoplasms
36
Sarcoma
34
Recurrence
31
Carcinoma
30
Nasopharyngeal Neoplasms
28
Interventions
pembrolizumab
1
Histamine H2 Antagonists
1
Famotidine
1
Angptl4 protein, mouse
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Liposarcoma
×
Head & Neck
×
Clear all
NCT06789172
2026-05-22
INVOKE
Epkin
Phase 1
Recruiting
166 enrolled